CTNNB1 and colorectal carcinoma: Studies indicate that 93% of patients with CRC exhibit alterations in the Wnt signaling pathway, primarily involving the biallelic gene inactivation of adenomatous polyposis coli (APC) and mutations in catenin beta 1 (CTNNB1) [59].